vs

Side-by-side financial comparison of CRISPR Therapeutics AG (CRSP) and KINGSWAY FINANCIAL SERVICES INC (KFS). Click either name above to swap in a different company.

KINGSWAY FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($38.6M vs $35.7M, roughly 1.1× CRISPR Therapeutics AG). KINGSWAY FINANCIAL SERVICES INC runs the higher net margin — -4.1% vs -104.5%, a 100.4% gap on every dollar of revenue. On growth, KINGSWAY FINANCIAL SERVICES INC posted the faster year-over-year revenue change (30.1% vs -82.3%).

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. I...

Kingsway Financial Services Inc. is a specialty financial holding firm that primarily offers property and casualty insurance products, including personal auto, commercial liability and property coverage. It operates mainly across North American markets, catering to individual consumers, small business owners and niche commercial client segments.

CRSP vs KFS — Head-to-Head

Bigger by revenue
KFS
KFS
1.1× larger
KFS
$38.6M
$35.7M
CRSP
Growing faster (revenue YoY)
KFS
KFS
+112.3% gap
KFS
30.1%
-82.3%
CRSP
Higher net margin
KFS
KFS
100.4% more per $
KFS
-4.1%
-104.5%
CRSP

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CRSP
CRSP
KFS
KFS
Revenue
$35.7M
$38.6M
Net Profit
$-37.3M
$-1.6M
Gross Margin
Operating Margin
-181.0%
0.8%
Net Margin
-104.5%
-4.1%
Revenue YoY
-82.3%
30.1%
Net Profit YoY
-141.8%
-7.8%
EPS (diluted)
$-0.41
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRSP
CRSP
KFS
KFS
Q4 25
$38.6M
Q3 25
$37.2M
Q2 25
$30.9M
Q1 25
$28.3M
Q4 24
$35.7M
$29.6M
Q3 24
$27.1M
Q2 24
$26.4M
Q1 24
$26.2M
Net Profit
CRSP
CRSP
KFS
KFS
Q4 25
$-1.6M
Q3 25
$-2.4M
Q2 25
$-3.2M
Q1 25
$-3.1M
Q4 24
$-37.3M
$-1.5M
Q3 24
$-2.3M
Q2 24
$-2.2M
Q1 24
$-2.3M
Operating Margin
CRSP
CRSP
KFS
KFS
Q4 25
0.8%
Q3 25
-2.3%
Q2 25
-3.6%
Q1 25
-2.5%
Q4 24
-181.0%
6.5%
Q3 24
-2.5%
Q2 24
0.5%
Q1 24
2.9%
Net Margin
CRSP
CRSP
KFS
KFS
Q4 25
-4.1%
Q3 25
-6.5%
Q2 25
-10.2%
Q1 25
-10.9%
Q4 24
-104.5%
-5.0%
Q3 24
-8.5%
Q2 24
-8.3%
Q1 24
-8.9%
EPS (diluted)
CRSP
CRSP
KFS
KFS
Q4 25
$-0.07
Q3 25
$-0.10
Q2 25
$-0.13
Q1 25
$-0.13
Q4 24
$-0.41
$-0.08
Q3 24
$-0.10
Q2 24
$-0.08
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRSP
CRSP
KFS
KFS
Cash + ST InvestmentsLiquidity on hand
$1.9B
$8.5M
Total DebtLower is stronger
$70.7M
Stockholders' EquityBook value
$1.9B
$15.2M
Total Assets
$2.2B
$231.5M
Debt / EquityLower = less leverage
4.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRSP
CRSP
KFS
KFS
Q4 25
$8.5M
Q3 25
$9.5M
Q2 25
$12.3M
Q1 25
$6.5M
Q4 24
$1.9B
$5.7M
Q3 24
$6.7M
Q2 24
$9.8M
Q1 24
$12.3M
Total Debt
CRSP
CRSP
KFS
KFS
Q4 25
$70.7M
Q3 25
$70.7M
Q2 25
$58.3M
Q1 25
$59.5M
Q4 24
$57.5M
Q3 24
$58.5M
Q2 24
$47.3M
Q1 24
$47.1M
Stockholders' Equity
CRSP
CRSP
KFS
KFS
Q4 25
$15.2M
Q3 25
$16.6M
Q2 25
$17.4M
Q1 25
$5.5M
Q4 24
$1.9B
$8.4M
Q3 24
$9.9M
Q2 24
$20.7M
Q1 24
$23.6M
Total Assets
CRSP
CRSP
KFS
KFS
Q4 25
$231.5M
Q3 25
$235.1M
Q2 25
$207.7M
Q1 25
$192.1M
Q4 24
$2.2B
$186.6M
Q3 24
$191.1M
Q2 24
$192.3M
Q1 24
$198.0M
Debt / Equity
CRSP
CRSP
KFS
KFS
Q4 25
4.66×
Q3 25
4.25×
Q2 25
3.34×
Q1 25
10.91×
Q4 24
6.84×
Q3 24
5.88×
Q2 24
2.29×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRSP
CRSP
KFS
KFS
Operating Cash FlowLast quarter
$-50.0M
$-3.0K
Free Cash FlowOCF − Capex
$-50.3M
FCF MarginFCF / Revenue
-140.9%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-325.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRSP
CRSP
KFS
KFS
Q4 25
$-3.0K
Q3 25
$1.5M
Q2 25
$337.0K
Q1 25
$-1.8M
Q4 24
$-50.0M
$1.1M
Q3 24
$368.0K
Q2 24
$557.0K
Q1 24
$249.0K
Free Cash Flow
CRSP
CRSP
KFS
KFS
Q4 25
Q3 25
$1.3M
Q2 25
Q1 25
Q4 24
$-50.3M
Q3 24
Q2 24
Q1 24
FCF Margin
CRSP
CRSP
KFS
KFS
Q4 25
Q3 25
3.4%
Q2 25
Q1 25
Q4 24
-140.9%
Q3 24
Q2 24
Q1 24
Capex Intensity
CRSP
CRSP
KFS
KFS
Q4 25
Q3 25
0.5%
Q2 25
Q1 25
Q4 24
0.7%
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRSP
CRSP

Collaboration Revenue$35.0M98%
Grant$2.3M6%

KFS
KFS

Other$14.8M38%
Roundhouse Electric Equipment Co Inc$9.7M25%
MLC Plumbing LLC$5.7M15%
Systems Products International Incspi$3.8M10%
Advanced Plumbing And Drain$2.9M8%
Southside Plumbing$1.7M4%

Related Comparisons